Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 8,092 | 14,123 | 14,578 | 12,093 | 12,814 |
| Operating Income | -8,092 | -14,123 | -14,578 | -12,093 | -12,814 |
| Other Income | 126 | 20 | 0 | 0 | 67 |
| Pre-tax Income | -7,967 | -14,103 | -14,578 | -12,093 | -12,748 |
| Net Income Continuous | -7,967 | -14,103 | -14,578 | -12,093 | -12,748 |
| Net Income | $-7,967 | $-14,103 | $-14,578 | $-12,093 | $-12,748 |
| EPS Basic Total Ops | -5.32 | -17.45 | -23.00 | -22.40 | -29.80 |
| EPS Basic Continuous Ops | -5.32 | -17.45 | -23.01 | -22.36 | -29.87 |
| EPS Diluted Total Ops | -5.32 | -17.45 | -23.00 | -22.40 | -29.80 |
| EPS Diluted Continuous Ops | -5.32 | -17.45 | -23.01 | -22.36 | -29.87 |
| EPS Diluted Before Non-Recurring Items | -5.32 | -17.40 | -23.00 | -22.40 | -29.80 |
| EBITDA(a) | $-8,092 | $-14,123 | $-14,578 | $-12,093 | $-12,814 |